---
$id: https://graph.org.ai/products/commodity/51361920
$type: Product
source: UNSPSC
code: "51361920"
title: "Secobarbital"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Secobarbital

**UNSPSC Code**: 51361920
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C12H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1P7H87IN75, chemically known as 2,4,6 (1h,3h,5h)-pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, monosodium salt but generally known as secobarbital, which bears US NIH Compound Identifier 5193. European Medicines Agency schedules Secobarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10468MIG. The term SECOBARBITAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules secobarbital in its Anatomical Therapeutic Chemical (ATC) Classification. SECOBARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule secobarbital under HS 29335390 and SITC 51576. As of Q4 2014, SECOBARBITAL remains the US FDA Preferred Term for this commodity. Secobarbital bears US NLM identifiers UMLS ID C0036516 and NCI Concept Code C61937. SMILES: CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C.

